Scientists have uncovered new genetic clues that explain why some prostate cancers remain slow-growing while others become life-threatening. Scientists from UCLA, the University of Toronto and the ...

An international study reports that the combination of two drugs could significantly retard the development of a dangerous form of prostate cancer in men who have specific mutations in DNA repair ...

A powerful new drug combination—niraparib added to standard prostate cancer therapy—has been shown to significantly delay disease progression in men with specific DNA repair gene mutations. In the ...